Simonenko, M;
Hansen, D;
Niebauer, J;
Volterrani, M;
Adamopoulos, S;
Amarelli, C;
Ambrosetti, M;
Anker, SD;
Bayes-Genis, A;
Gal, TB;
et al.
Simonenko, M; Hansen, D; Niebauer, J; Volterrani, M; Adamopoulos, S; Amarelli, C; Ambrosetti, M; Anker, SD; Bayes-Genis, A; Gal, TB; Bowen, TS; Cacciatore, F; Caminiti, G; Cavarretta, E; Chioncel, O; Coats, AJS; Cohen-Solal, A; D'Ascenzi, F; de Pablo Zarzosa, C; Gevaert, AB; Gustafsson, F; Kemps, H; Hill, L; Jaarsma, T; Jankowska, E; Joyce, E; Krankel, N; Lainscak, M; Lund, LH; Moura, B; Nytrøen, K; Osto, E; Piepoli, M; Potena, L; Rakisheva, A; Rosano, G; Savarese, G; Seferovic, PM; Thompson, DR; Thum, T; Van Craenenbroeck, EM
(2024)
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT.
Eur J Prev Cardiol, 31 (11).
pp. 1385-1399.
ISSN 2047-4881
https://doi.org/10.1093/eurjpc/zwae179
SGUL Authors: Rosano, Giuseppe Massimo Claudio
Abstract
Little is known either about either physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines or position papers highlighting the features of prevention and rehabilitation after HTx. The aims of this scientific statement are (i) to explain the importance of prevention and rehabilitation after HTx, and (ii) to promote the factors (modifiable/non-modifiable) that should be addressed after HTx to improve patients' physical capacity, quality of life and survival. All HTx team members have their role to play in the care of these patients and multidisciplinary prevention and rehabilitation programmes designed for transplant recipients. HTx recipients are clearly not healthy disease-free subjects yet they also significantly differ from heart failure patients or those who are supported with mechanical circulatory support. Therefore, prevention and rehabilitation after HTx both need to be specifically tailored to this patient population and be multidisciplinary in nature. Prevention and rehabilitation programmes should be initiated early after HTx and continued during the entire post-transplant journey. This clinical consensus.
Item Type: |
Article
|
Additional Information: |
Correction available at https://doi.org/10.1093/eurjpc/zwae226
© The Authors 2024. Published by John Wiley & Sons Limited and Oxford University Press on behalf of the European Society of Cardiology, and Frontiers Media SA on behalf of the European Society for Organ Transplantation.
This is an open access article under the CC-BY license (https://creativecommons.org/licenses/by/4.0/) which permits use and distribution in any medium, provided the original author(s) and the copyright owner(s) are credited and that the original publication in the European Journal of Heart Failure, Transplant International and the European Journal of Preventive Cardiology is cited, in accordance with accepted academic practice. |
Keywords: |
Diabetes, Dyslipidaemia, Exercise training, Heart failure, Heart transplantation, Hypertension, Physical activity, Prevention, Primary prevention, Rehabilitation, Risk factors, Secondary prevention, Heart Transplantation, Humans, Consensus, Heart Failure, Cardiac Rehabilitation, Quality of Life, Risk Factors, Treatment Outcome, Risk Reduction Behavior, Humans, Treatment Outcome, Heart Transplantation, Risk Factors, Risk Reduction Behavior, Consensus, Quality of Life, Heart Failure, Cardiac Rehabilitation, Diabetes, Dyslipidaemia, Exercise training, Heart failure, Heart transplantation, Hypertension, Physical activity, Prevention, Primary prevention, Rehabilitation, Risk factors, Secondary prevention, Diabetes, Dyslipidaemia, Exercise training, Heart failure, Heart transplantation, Hypertension, Physical activity, Prevention, Primary prevention, Rehabilitation, Risk factors, Secondary prevention |
SGUL Research Institute / Research Centre: |
?? 61 ?? |
Journal or Publication Title: |
Eur J Prev Cardiol |
ISSN: |
2047-4881 |
Language: |
eng |
Dates: |
Date | Event |
---|
22 August 2024 | Published | 19 June 2024 | Published Online | 21 February 2024 | Accepted |
|
Publisher License: |
Creative Commons: Attribution 4.0 |
PubMed ID: |
38894688 |
Web of Science ID: |
WOS:001249738800001 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/116618 |
Publisher's version: |
https://doi.org/10.1093/eurjpc/zwae179 |
Statistics
Item downloaded times since 04 Sep 2024.
Actions (login required)
|
Edit Item |